NVP Healthcare clinical trials
The registry lists 22 studies whose lead sponsor is NVP Healthcare. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 1, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 22studies on the registry
- 2open to participants now
- 1phase 3 study under way
- 1reach primary completion within a year
Get an email when these change. Save the NVP Healthcare studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
What it is testing
The drugs NVP Healthcare’s studies test, most studies first; none is open now — 5 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
Coming up
1 of NVP Healthcare’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- 1SSep
- OOct
- NNov
The study
Add it to your calendar (.ics) → With an account.
All 22 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 13
- 14
- 15
- 16
- 17
- 18
- 419
- 20
- 21
- 22
- 23
- 24
- 25
- 126
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to NVP Healthcare.
- NVP Healthcare22 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 22 of 22.
- Efficacy and Safety of NVP-NK4146 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseEnrolling by invitationNCT06761066Not applicable
- To Evaluate the Safety and Efficacy of NVP-2203 Tablet in PatientsRecruitingNCT05856487Phase 3
- To Evaluate the Safety and the Pharmacokinetics of NVP-2203CompletedNCT05725252Phase 1
- Pharmacokinetic Characteristics and Safety After Administration of NVP-2002CompletedNCT04961905Phase 1
- NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)CompletedNCT05354713Phase 1
- Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy SubjectsCompletedNCT05141110Phase 1
- NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult VolunteersCompletedNCT04905342Phase 1
- Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy SubjectsCompletedNCT05023031Phase 1
- Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back PainCompletedNCT04082975Phase 3
- Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2CompletedNCT04780386Phase 1
- Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2CompletedNCT04181437Phase 1
- Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2CompletedNCT03802526Phase 1
- Efficacy and Safety of NVP-1203 in Patients With Acute Low Back PainCompletedNCT03341832Phase 2
- Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203WithdrawnNCT02289274Phase 1
- Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1603-1 and NVP-1603-2WithdrawnNCT03220399Phase 1
- A Study to Evaluate the Food Effect on the Pharmacokinetics of NVP-1203CompletedNCT02289404Phase 1
- The Food Effect on the Pharmacokinetics of NVP-1402CompletedNCT03340480Phase 1
- A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402CompletedNCT02897726Phase 1
- Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mgCompletedNCT01885520Phase 1
- Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and EzetimibeCompletedNCT02029625Phase 1
- to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male VolunteersCompletedNCT02289430Phase 1
- Clinical Trial to Compare the Pharmacokinetics and Safety of Eperisone HCl SR Tablet 75mg and Myonal Tablet 50mgCompletedNCT01775566